MFS
INSY

MSI Financial Services’s Insys Therapeutics, Inc. INSY Stock Holding History

MSI Financial Services’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$25K Buy
2,700
+600
+29% +$6.78K ﹤0.01% 2279
2016
Q3 		$25K Buy
2,100
+1,500
+250% +$22.8K ﹤0.01% 2249
2016
Q2 		$8K Hold
600
– – ﹤0.01% 2916
2016
Q1 		$10K Hold
600
– – ﹤0.01% 2787
2015
Q4 		$17K Buy
600
+200
+50% +$5.54K ﹤0.01% 2427
2015
Q3 		$11K Buy
+400
New +$14.7K ﹤0.01% 2054

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MSI Financial Services's INSY Position: Q4 2016 in Review

MSI Financial Services increased its Insys Therapeutics, Inc. (INSY) stake by 29% in Q4 2016, buying an estimated $6.78K and bringing the position to 2,700 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #2279.

MSI Financial Services first reported a position in INSY in Q3 2015 and has held it in 6 quarters since. 138 funds tracked by Wall St. Rank hold INSY as of Q4 2016.

  • MSI Financial Services held 2,700 shares of Insys Therapeutics, Inc. worth $25K as of Q4 2016.
  • MSI Financial Services bought 600 Insys Therapeutics, Inc. shares in Q4 2016, an estimated $6.78K.
  • Insys Therapeutics, Inc. made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2279 holding.
  • MSI Financial Services first reported a position in Insys Therapeutics, Inc. in Q3 2015 and has held it in 6 quarters since.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.